Pharming Group N.V.

NASDAQ:PHAR

Biotechnology

Healthcare
$12.48 +2.19%

+$0.28 today

Market cap
$882.43M
Beta
0.10
P/E (TTM)
77.0
EPS (TTM)
$0.02
52W Low $9.54High $21.34

Volume 0.01M

Average 0.01M

Balance Sheet

Inspect the capital base behind the business.

Assets

$499.81M

FY 2025 · Annual

+20.7% YoY

Liabilities

$222.79M

FY 2025 · Annual

+20.3% YoY

Equity

$277.02M

FY 2025 · Annual

+21.0% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents217.59M207.34M61.74M56.89M146.02M
Short-term Investments00151.68M116.96M33.79M
Net Receivables31.28M25.33M42.62M51.95M54.69M
Inventory30.96M42.33M56.76M57.7M64.88M
Other Current Assets257.35K213K001K
Total Current Assets282.8M277.5M316.34M288.32M299.38M
Property, Plant & Equipment (Net)37.6M39.15M33.47M24.12M23.96M
Goodwill0000135.5M
Intangible Assets95.04M75.12M71.27M63.21M0
Long-term Investments9.81M9.73M10.4M4.38M9.87M
Tax Assets24.05M22.97M29.76M31.63M31.01M
Other Non-current Assets1.14M1.33M1.62M2.52M93.98K
Total Non-current Assets167.64M148.3M146.51M125.86M200.43M
Total Assets450.44M425.8M462.85M414.18M499.81M
Account Payables8.62M8.75M16.02M10.46M105.87M
Short-term Debt2.13M1.77M1.82M4.4M5.34M
Tax Payables1.71M2.1M6.23M3.4M0
Deferred Revenue00000
Other Current Liabilities0003.4M1.22M
Total Current Liabilities53.02M59.7M77.97M76.42M115.79M
Long-term Debt157.59M131.62M136.6M80.93M92.72M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities187.06K0000
Total Non-current Liabilities178.7M161.46M166.11M108.85M107.07M
Total Liabilities231.73M221.16M244.07M185.27M222.79M
Common Stock8.42M7.51M7.67M8.04M8.01M
Retained Earnings(309.69M)(256.43M)(265.26M)(285.27M)(272.9M)
Accumulated OCI3.85M(8.74M)(2.06M)(216.42K)0
Other Stockholders Equity000028.81M
Minority Interest00000
Total Equity218.71M204.64M218.78M228.91M277.02M
Total Debt183.39M166.69M171.55M116.3M115.78M
Net Debt(34.2M)(40.65M)109.8M59.41M(30.25M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$53.1M
Short-term Investments$117.8M
Receivables$60.0M
Inventory$64.6M
Total Current Assets$295.5M
PP&E (Net)$23.1M
Intangible Assets$131.0M
Long-term Investments$9.0M
Tax Assets$30.7M
Other Non-current$92.0K
Total Non-current Assets$193.9M
Total Assets$489.4M

Analysis

Selected assets total $489.4M for Latest. The largest visible component is Intangible Assets at $131.0M, about 26.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 6, 2026
6-K6-K filingOct 27, 2026
6-K6-K filingOct 22, 2026
6-K6-K filingOct 14, 2026
6-K6-K filingSep 29, 2026

How much cash does PHAR have?

Pharming Group N.V. (PHAR) reported $146.02M in cash and equivalents in fiscal 2025.

How much debt does PHAR carry?

Pharming Group N.V. (PHAR) reported $115.78M of total debt, with net debt of -$30.25M.